Spanish Red Biotech Pipeline

Leitat

Ready-to-use transport kits for xenobiotic interaction studies

Type: Others
Therapeutic area: Others
Indication: To identify xenobiotic interactions for regulatory purposes
Phase: 5Ready to Market, 4Register, 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: Europe